Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.6 CHF | +0.25% | -4.00% | +12.18% |
04-09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
04-04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.18% | 516M | |
+19.64% | 42.68B | |
-3.13% | 42.4B | |
+45.32% | 40.04B | |
-6.20% | 28.31B | |
+7.65% | 24.94B | |
-20.06% | 18.96B | |
+29.96% | 12.3B | |
-2.77% | 11.95B | |
-2.81% | 11.55B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Basilea Pharmaceutica : Invasive Aspergillosis Drug Isavuconazole Accepted For Regulatory Review in China